Moreno Cesar L, Ehrlich Michelle E, Mobbs Charles V
Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Friedman Brain Institute, New York, NY 10029, USA.
Friedman Brain Institute, New York, NY 10029, USA; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Neurobiol Dis. 2016 Jan;85:25-34. doi: 10.1016/j.nbd.2015.09.012. Epub 2015 Oct 17.
Huntington's disease (HD) is a fatal neurodegenerative disease characterized by metabolic, cognitive, and motor deficits. HD is caused by an expanded CAG repeat in the first exon of the HTT gene, resulting in an expanded polyglutamine section. Dietary restriction (DR) increases lifespan and ameliorates age-related pathologies, including in a model of HD, but the mechanisms mediating these protective effects are unknown. We report metabolic and behavioral effects of DR in the full-length YAC128 HD mouse model, and associated transcriptional changes in hypothalamus and striatum. DR corrected many effects of the transgene including increased body weight, decreased blood glucose, and impaired motor function. These changes were associated with reduced striatal human (but not mouse) HTT expression, as well as alteration in gene expression regulating histone acetylation modifications, particularly Hdac2. Other mRNAs related to Huntington's pathology in striatal tissue showed significant modulation by the transgene, dietary restriction or both. These results establish a protective role of DR in a transgenic model that contains the complete human HTT gene and for the first time suggest a role for DR in lowering HTT level, which correlates with severity of symptoms.
亨廷顿舞蹈症(HD)是一种致命的神经退行性疾病,其特征为代谢、认知和运动功能缺陷。HD由HTT基因第一外显子中CAG重复序列扩增所致,导致多聚谷氨酰胺区段延长。饮食限制(DR)可延长寿命并改善与年龄相关的病理状况,包括在HD模型中,但介导这些保护作用的机制尚不清楚。我们报告了DR在全长YAC128 HD小鼠模型中的代谢和行为影响,以及下丘脑和纹状体相关的转录变化。DR纠正了转基因的许多影响,包括体重增加、血糖降低和运动功能受损。这些变化与纹状体中人(而非小鼠)HTT表达降低以及调节组蛋白乙酰化修饰的基因表达改变有关,尤其是Hdac2。纹状体组织中与亨廷顿病理相关的其他mRNA显示受转基因、饮食限制或两者的显著调节。这些结果确立了DR在包含完整人类HTT基因的转基因模型中的保护作用,并首次表明DR在降低HTT水平方面的作用,这与症状严重程度相关。